(Q40720366)

23 September 2017

1 reference

title

Aminoglycoside dosage regimens. Is once a day enough? (English)

1 reference

23 September 2017

W N Hustinx

1

1 reference

23 September 2017

I M Hoepelman

series ordinal

2

1 reference

23 September 2017

publication date

1 December 1993

1 reference

Clinical Pharmacokinetics

23 September 2017

published in

1 reference

23 September 2017

volume

25

1 reference

23 September 2017

issue

6

1 reference

23 September 2017

page(s)

427-432

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199325060-00002

23 September 2017

exact match

0 references

cites work

Once versus thrice daily gentamicin in patients with serious infections

1 reference

12 December 2020

Once-daily aminoglycoside administration: new strategies for an old drug

1 reference

12 December 2020

Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin

1 reference

12 December 2020

Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man

1 reference

12 December 2020

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

12 December 2020

Postantibiotic suppression of bacterial growth

1 reference

12 December 2020

Once daily dosing of aminoglycoside: one step forward

1 reference

12 December 2020

The postantibiotic effect

1 reference

12 December 2020

Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections

1 reference

12 December 2020

Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia

1 reference

12 December 2020

Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method

1 reference

12 December 2020

A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections

1 reference

12 December 2020

Once-daily dosing decreases renal accumulation of gentamicin and netilmicin

1 reference

12 December 2020

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

1 reference

12 December 2020

In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats.

1 reference

12 December 2020

A critical reevaluation of the "therapeutic range" of aminoglycosides

1 reference

12 December 2020

Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia

1 reference

12 December 2020

Synergistic post-antibiotic effect of amikacin and beta-lactam antibiotics on Enterococcus faecalis

1 reference

12 December 2020

Once-daily aminoglycoside therapy

1 reference

12 December 2020

Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin

1 reference

12 December 2020

Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Scandinavian Amikacin Once Daily Study Group

1 reference

12 December 2020

Netilmicin in the treatment of gram-negative bacteremia: single daily versus multiple daily dosage

1 reference

12 December 2020

Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot study

1 reference

12 December 2020

Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group

1 reference

12 December 2020

The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess

1 reference

12 December 2020

Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits

1 reference

12 December 2020

Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis

1 reference

12 December 2020

In vivo postantibiotic effect in a thigh infection in neutropenic mice

1 reference

12 December 2020

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

12 December 2020

Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.

1 reference

12 December 2020

A study of amikacin given once versus twice daily in serious infections

1 reference

12 December 2020

Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli

1 reference

12 December 2020

Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides

1 reference

12 December 2020

Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections

1 reference

12 December 2020

The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens

1 reference

12 December 2020

The postantibiotic effect: a review of in vitro and in vivo data

1 reference

12 December 2020

Determinants of efficacy and toxicity of aminoglycosides

1 reference

12 December 2020

10.2165/00003088-199325060-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

23 September 2017

1030238617

0 references

1 reference